CD8A and metabolic dysfunction-associated steatohepatitis: Compared to HCC induced by HBV/HCV, HCC driven by NASH shows a weaker immune response to tumor specific antigen (TAA) owing to the fact that CD8+ T cells with strong expression of CTLA-4 is high (141).